<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE sequence-cwu SYSTEM "us-sequence-listing-2004-03-09.dtd" [ ]>
<sequence-cwu id="SEQLST-0">
<publication-reference>
<document-id>
<country>US</country>
<doc-number>07521258</doc-number>
<kind>B2</kind>
<date>20090421</date>
</document-id>
</publication-reference>
<number>1</number>
<table frame="none" colsep="0" rowsep="0" tabstyle="monospace">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="441pt" align="left"/>
<tbody valign="top">
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"/>
</row>
<row>
<entry>                               SEQUENCE LISTING </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(1) GENERAL INFORMATION: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>   (iii) NUMBER OF SEQUENCES: 21 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 1: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 701 base pairs </entry>
</row>
<row>
<entry>          (B) TYPE: nucleic acid </entry>
</row>
<row>
<entry>          (C) STRANDEDNESS: double </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: DNA (genomic) </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>   (iii) HYPOTHETICAL: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (vi) ORIGINAL SOURCE: </entry>
</row>
<row>
<entry>          (A) ORGANISM: Mus musculus </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>CCAGCAGCTG CAAGGTGCAA GAAGAAGAAG ATCCCAGGGA GGAAAATGTG CTGGAGACCC     60 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>CTGTGTCGGN TTCCTGTGGC TTTGGTCCTA TCTGTCTTAT GTTCAAGCAG TGCCTATCCA    120 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>GAAAGTCCAG GATGACACCA AAACCCTCAT CAAGACCATT GTCACCAGGA TCAATGACAT    180 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>TTCACACACG CAGTCGGTAT CCGCCAAGCA GAGGGTCACT GGCTTGGACT TCATTCCTGG    240 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>GCTTCACCCC ATTCTGAGTT GTTCCAAGAT GGACCAGACT CTGGCAGTCT ATCAACAGGT    300 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>CCTCACCAGC CTGCCTTCCC AAAATGTGCT GCAGATAGCC AATGACCTGG AGAATCTCCG    360 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>AGACCTCCTC CATCTGCTGG CCTTCTCCAA GAGCTGCTCC CTGCCTCAGA CCAGTGGCCT    420 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>GCAGAAGCCA GAGAGCCTGG ATGGCGTCCT GGAAGCCTCA CTCTACTCCA CAGAGGTGGT    480 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>GGCTTTGAGC AGGCTGCAGG GCTCTCTGCA GGACATTCTT CAACAGTTGG ATGTTAGCCC    540 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>TGAATGCTGA AGTTTCAAAG GCCACNCAGG CTCCCAAGAA TCATGTAGAG GGAAGAAACC    600 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>TTGGCTTCCA GGGGTCTTCA GGANNGAAGA GNAGCNCATG TGCACACNNN ATCCANNNNT    660 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>CATTCANTTT CTCTCCCTCC TGTAGACCAC NNNNCCATNN N                        701 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 2: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 167 amino acids </entry>
</row>
<row>
<entry>          (B) TYPE: amino acid </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: protein </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: Murine ob protein </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (vi) ORIGINAL SOURCE: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Met Cys Trp Arg Pro Leu Cys Arg Phe Leu Trp Leu Trp Ser Tyr Leu </entry>
</row>
<row>
<entry>  1               5                  10                  15 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ser Tyr Val Gln Ala Val Pro Ile Gln Lys Val Gln Asp Asp Thr Lys </entry>
</row>
<row>
<entry>             20                  25                  30 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Thr Leu Ile Lys Thr Ile Val Thr Arg Ile Asn Asp Ile Ser His Thr </entry>
</row>
<row>
<entry>         35                  40                  45 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Gln Ser Val Ser Ala Lys Gln Arg Val Thr Gly Leu Asp Phe Ile Pro </entry>
</row>
<row>
<entry>     50                  55                  60 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Gly Leu His Pro Ile Leu Ser Leu Ser Lys Met Asp Gln Thr Leu Ala </entry>
</row>
<row>
<entry> 65                  70                  75                  80 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Val Tyr Gln Gln Val Leu Thr Ser Leu Pro Ser Gln Asn Val Leu Gln </entry>
</row>
<row>
<entry>                 85                  90                  95 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ile Ala Asn Asp Leu Glu Asn Leu Arg Asp Leu Leu His Leu Leu Ala </entry>
</row>
<row>
<entry>            100                 105                 110 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Phe Ser Lys Ser Cys Ser Leu Pro Gln Thr Ser Gly Leu Gln Lys Pro </entry>
</row>
<row>
<entry>        115                 120                 125 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Glu Ser Leu Asp Gly Val Leu Glu Ala Ser Leu Tyr Ser Thr Glu Val </entry>
</row>
<row>
<entry>    130                 135                 140 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Val Ala Leu Ser Arg Leu Gln Gly Ser Leu Gln Asp Ile Leu Gln Gln </entry>
</row>
<row>
<entry>145                 150                 155                 160 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Leu Asp Val Ser Pro Glu Cys </entry>
</row>
<row>
<entry>                165 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 3: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 701 base pairs </entry>
</row>
<row>
<entry>          (B) TYPE: nucleic acid </entry>
</row>
<row>
<entry>          (C) STRANDEDNESS: double </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: DNA (genomic) </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>   (iii) HYPOTHETICAL: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (vi) ORIGINAL SOURCE: </entry>
</row>
<row>
<entry>          (A) ORGANISM: Mus musculus </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>NNNGNNGTTG CAAGGCCCAA GAAGCCCANN NTCCTGGGAA GGAAAATGCA TTGGGGAACC     60 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>CTGTGNCGGA TTCTTGTGGC TTTGGCCCTA TCTTTTCTAT GTCCAAGCTG TGCCCATCCA    120 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>AAAAGTCCAA GATGACACCA AAACCCTCAT CAAGACAATT GTCACCAGGA TCAATGACAT    180 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>TTCACACACG CAGTCAGTCT CCTCCAAACA GAAAGTCACC GGTTTGGACT TCATTCCTGG    240 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>GCTCCACCCC ATCCTGACCT TATCCAAGAT GGACCAGACA CTGGCAGTCT ACCAACAGAT    300 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>CCTCACCAGT ATGCCTTCCA GAAACGTGAT CCAAATATCC AACGACCTGG AGAACCTCCG    360 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>GGATCTTCTT CACGTGCTGG CCTTCTCTAA GAGCTGCCAC TTGCCCTGGG CCAGTGGCCT    420 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>GGAGACCTTG GACAGCCTGG GGGGTGTCCT GGAAGCTTCA GGCTACTCCA CAGAGGTGGT    480 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>GGCCCTGAGC AGGCTGCAGG GGTCTCTGCA GGACATGCTG TGGCAGCTGG ACCTCAGCCC    540 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>TGGGTGCTGA GGCCTTGAAG GTCACTCTTC CTGCAAGGAC TNACGTTAAG GGAAGGAACT    600 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>CTGGTTTCCA GGTATCTCCA GGATTGAAGA GCATTGCATG GACACCCCTT ATCCAGGACT    660 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>CTGTCAATTT CCCTGACTCC TCTAAGCCAC TCTTCCAAAG G                        701 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 4: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 167 amino acids </entry>
</row>
<row>
<entry>          (B) TYPE: amino acid </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: protein </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: Human Ob protein </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (vi) ORIGINAL SOURCE: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Met His Trp Gly Thr Leu Cys Gly Phe Leu Trp Leu Trp Pro Tyr Leu </entry>
</row>
<row>
<entry> 1               5                   10                  15 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Phe Tyr Val Gln Ala Val Pro Ile Gln Lys Val Gln Asp Asp Thr Lys </entry>
</row>
<row>
<entry>             20                  25                  30 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Thr Leu Ile Lys Thr Ile Val Thr Arg Ile Asn Asp Ile Ser His Thr </entry>
</row>
<row>
<entry>         35                  40                  45 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Gln Ser Val Ser Ser Lys Gln Lys Val Thr Gly Leu Asp Phe Ile Pro </entry>
</row>
<row>
<entry>     50                  55                  60 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Gly Leu His Pro Ile Leu Thr Leu Ser Lys Met Asp Gln Thr Leu Ala </entry>
</row>
<row>
<entry> 65                  70                  75                  80 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Val Tyr Gln Gln Ile Leu Thr Ser Met Pro Ser Arg Asn Val Ile Gln </entry>
</row>
<row>
<entry>                 85                  90                  95 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ile Ser Asn Asp Leu Glu Asn Leu Arg Asp Leu Leu His Val Leu Ala </entry>
</row>
<row>
<entry>            100                 105                 110 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Phe Ser Lys Ser Cys His Leu Pro Trp Ala Ser Gly Leu Glu Thr Leu </entry>
</row>
<row>
<entry>        115                 120                 125 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Asp Ser Leu Gly Gly Val Leu Glu Ala Ser Gly Tyr Ser Thr Glu Val </entry>
</row>
<row>
<entry>    130                 135                 140 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Val Ala Leu Ser Arg Leu Gln Gly Ser Leu Gln Asp Met Leu Trp Gln </entry>
</row>
<row>
<entry>145                 150                 155                 160 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Leu Asp Leu Ser Pro Gly Cys </entry>
</row>
<row>
<entry>                165 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 5: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 166 amino acids </entry>
</row>
<row>
<entry>          (B) TYPE: amino acid </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: protein </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: Murine ob protein harboring Gln deletionat </entry>
</row>
<row>
<entry>              position 49 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (vi) ORIGINAL SOURCE: </entry>
</row>
<row>
<entry>          (A) ORGANISM: Murine </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Met Cys Trp Arg Pro Leu Cys Arg Phe Leu Trp Leu Trp Ser Tyr Leu </entry>
</row>
<row>
<entry>  1               5                  10                  15 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ser Tyr Val Gln Ala Val Pro Ile Gln Lys Val Gln Asp Asp Thr Lys </entry>
</row>
<row>
<entry>             20                  25                  30 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Thr Leu Ile Lys Thr Ile Val Thr Arg Ile Asn Asp Ile Ser His Thr </entry>
</row>
<row>
<entry>         35                  40                  45 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ser Val Ser Ala Lys Gln Arg Val Thr Gly Leu Asp Phe Ile Pro Gly </entry>
</row>
<row>
<entry>     50                  55                  60 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Leu His Pro Ile Leu Ser Leu Ser Lys Met Asp Gln Thr Leu Ala Val </entry>
</row>
<row>
<entry> 65                  70                  75                  80 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Tyr Gln Gln Val Leu Thr Ser Leu Pro Ser Gln Asn Val Leu Gln Ile </entry>
</row>
<row>
<entry>                 85                  90                  95 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ala Asn Asp Leu Glu Asn Leu Arg Asp Leu Leu His Leu Leu Ala Phe </entry>
</row>
<row>
<entry>            100                 105                 110 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ser Lys Ser Cys Ser Leu Pro Gln Thr Ser Gly Leu Gln Lys Pro Glu </entry>
</row>
<row>
<entry>        115                 120                 125 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ser Leu Asp Gly Val Leu Glu Ala Ser Leu Tyr Ser Thr Glu Val Val </entry>
</row>
<row>
<entry>    130                 135                 140 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ala Leu Ser Arg Leu Gln Gly Ser Leu Gln Asp Ile Leu Gln Gln Leu </entry>
</row>
<row>
<entry>145                 150                 155                 160 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Asp Val Ser Pro Glu Cys </entry>
</row>
<row>
<entry>                165 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 6: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 166 amino acids </entry>
</row>
<row>
<entry>          (B) TYPE: amino acid </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: protein </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: Ob protein harboring Gln deletion at </entry>
</row>
<row>
<entry>              position 49 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (vi) ORIGINAL SOURCE: </entry>
</row>
<row>
<entry>          (A) ORGANISM: Human </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Met His Trp Gly Thr Leu Cys Gly Phe Leu Trp Leu Trp Pro Tyr Leu </entry>
</row>
<row>
<entry>  1               5                  10                  15 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Phe Tyr Val Gln Ala Val Pro Ile Gln Lys Val Gln Asp Asp Thr Lys </entry>
</row>
<row>
<entry>             20                  25                  30 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Thr Leu Ile Lys Thr Ile Val Thr Arg Ile Asn Asp Ile Ser His Thr </entry>
</row>
<row>
<entry>         35                  40                  45 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ser Val Ser Ser Lys Gln Lys Val Thr Gly Leu Asp Phe Ile Pro Gly </entry>
</row>
<row>
<entry>     50                  55                  60 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Leu His Pro Ile Leu Thr Leu Ser Lys Met Asp Gln Thr Leu Ala Val </entry>
</row>
<row>
<entry> 65                  70                  75                  80 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Tyr Gln Gln Ile Leu Thr Ser Met Pro Ser Arg Asn Val Ile Gln Ile </entry>
</row>
<row>
<entry>                 85                  90                  95 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ser Asn Asp Leu Glu Asn Leu Arg Asp Leu Leu His Val Leu Ala Phe </entry>
</row>
<row>
<entry>            100                 105                 110 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ser Lys Ser Cys His Leu Pro Trp Ala Ser Gly Leu Glu Thr Leu Asp </entry>
</row>
<row>
<entry>        115                 120                 125 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ser Leu Gly Gly Val Leu Glu Ala Ser Gly Tyr Ser Thr Glu Val Val </entry>
</row>
<row>
<entry>    130                 135                 140 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ala Leu Ser Arg Leu Gln Gly Ser Leu Gln Asp Met Leu Trp Gln Leu </entry>
</row>
<row>
<entry>145                 150                 155                 160 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Asp Leu Ser Pro Gly Cys </entry>
</row>
<row>
<entry>                165 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 7: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 18 base pairs </entry>
</row>
<row>
<entry>          (B) TYPE: nucleic acid </entry>
</row>
<row>
<entry>          (C) STRANDEDNESS: single </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: DNA (primer) </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: PCR 5 primer for exon 2G7 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>   (iii) HYPOTHETICAL: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (iv) ANTI-SENSE: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>CCAGGGCAGG AAAATGTG                                                   18 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 8: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 22 base pairs </entry>
</row>
<row>
<entry>          (B) TYPE: nucleic acid </entry>
</row>
<row>
<entry>          (C) STRANDEDNESS: single </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: DNA (primer) </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: PCR 3 primer for exon 2G7 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>   (iii) HYPOTHETICAL: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (iv) ANTI-SENSE: YES </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>CATCCTGGAC TTTCTGGATA GG                                              22 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 9: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 176 base pairs </entry>
</row>
<row>
<entry>          (B) TYPE: nucleic acid </entry>
</row>
<row>
<entry>          (C) STRANDEDNESS: double </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: DNA (genomic) </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: exon 2G7 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>   (iii) HYPOTHETICAL: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (iv) ANTI-SENSE: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>GTGCAAGAAG AAGAAGATCC CAGGGCAGGA AAATGTGCTG GAGACCCCTG TGTCGGGTCC     60 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>NGTGGNTTTG GTCCTATCTG TCTTATGTNC AAGCAGTGCC TATCCAGAAA GTCCAGGATG    120 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>ACACCAAAAG CCTCATCAAG ACCATTGTCA NCAGGATCAC TGANATTTCA CACACG        176 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 10: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 15 amino acids </entry>
</row>
<row>
<entry>          (B) TYPE: amino acid </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: peptide </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: putative signal sequence of Murine Ob protein </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Phe Leu Trp Leu Trp Ser Tyr Leu Ser Tyr Val Gln Ala Val Pro </entry>
</row>
<row>
<entry>  1               5                  10                  15 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 11: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 287 base pairs </entry>
</row>
<row>
<entry>          (B) TYPE: nucleic acid </entry>
</row>
<row>
<entry>          (C) STRANDEDNESS: double </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: circular </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: DNA (plasmid) </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: pET-15b expression vector </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>   (iii) HYPOTHETICAL: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (iv) ANTI-SENSE: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ix) FEATURE: </entry>
</row>
<row>
<entry>          (A) NAME/KEY: T7 promoter </entry>
</row>
<row>
<entry>          (B) LOCATION: 20..37 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ix) FEATURE: </entry>
</row>
<row>
<entry>          (A) NAME/KEY: lac operator </entry>
</row>
<row>
<entry>          (B) LOCATION: 39..64 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ix) FEATURE: </entry>
</row>
<row>
<entry>          (A) NAME/KEY: His-Tag </entry>
</row>
<row>
<entry>          (B) LOCATION: 123..137 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ix) FEATURE: </entry>
</row>
<row>
<entry>          (A) NAME/KEY: Thrombin cleavage site </entry>
</row>
<row>
<entry>          (B) LOCATION: 184..196 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>AGATCTCGAT CCCGCGAAAT TAATACGACT CACTATAGGG GAATTGTGAG CGGATAACAA     60 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>TTCCCCTCTA CAAATAATTT TGTTTAACTT TAAGAAGGAG ATATACCATG GGCAGCAGCC    120 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>ATCATCATCA TCATCACAGC AGCGGCCTGG TGCCGCGCGG CAGCCATATG CTCGAGGATC    180 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>CCGCTGCTAA CAAAGCCCGA AAGGAAGCTG AGTTGGCTGC TGCCACCGCT GAGCAATAAC    240 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>TAGCATAACC CCTTGGGGCC TCTAAACGGG TCTTGAGGGG TTTTTTG                  287 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 12: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 32 base pairs </entry>
</row>
<row>
<entry>          (B) TYPE: nucleic acid </entry>
</row>
<row>
<entry>          (C) STRANDEDNESS: single </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: DNA (primer) </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: Murine 5 primer </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>   (iii) HYPOTHETICAL: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (iv) ANTI-SENSE: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>CTTATGTTCA TATGGTGCCG ATCCAGAAAG TC                                   32 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 13: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 32 base pairs </entry>
</row>
<row>
<entry>          (B) TYPE: nucleic acid </entry>
</row>
<row>
<entry>          (C) STRANDEDNESS: single </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: DNA (primer) </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: Murine 3 primer </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>   (iii) HYPOTHETICAL: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (iv) ANTI-SENSE: Yes </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>TCCCTCTACA TATGTCTTGG GAGCCTGGTG GC                                   32 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 14: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 32 base pairs </entry>
</row>
<row>
<entry>          (B) TYPE: nucleic acid </entry>
</row>
<row>
<entry>          (C) STRANDEDNESS: single </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: DNA (primer) </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: Human 5 primer </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>   (iii) HYPOTHETICAL: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (iv) ANTI-SENSE: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>TCTATGTCCA TATGGTGCCG ATCCAAAAAG TC                                   32 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 15: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 32 base pairs </entry>
</row>
<row>
<entry>          (B) TYPE: nucleic acid </entry>
</row>
<row>
<entry>          (C) STRANDEDNESS: single </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: DNA (primer) </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: Human 3 primer </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>   (iii) HYPOTHETICAL: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (iv) ANTI-SENSE: Yes </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 15: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>TTCCTTCCCA TATGGTACTC CTTGCAGGAA GA                                   32 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 16: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 11 base pairs </entry>
</row>
<row>
<entry>          (B) TYPE: nucleic acid </entry>
</row>
<row>
<entry>          (C) STRANDEDNESS: double </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: cDNA </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: Normal splice acceptor site in ob </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>   (iii) HYPOTHETICAL: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (iv) ANTI-SENSE: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ix) FEATURE: </entry>
</row>
<row>
<entry>          (A) NAME/KEY: Splice acceptor site (with Glutamine) </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 16: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>AG CAG TCG GTA                                                     11 </entry>
</row>
<row>
<entry>   Gln Ser Val </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 17: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 11 base pairs </entry>
</row>
<row>
<entry>          (B) TYPE: nucleic acid </entry>
</row>
<row>
<entry>          (C) STRANDEDNESS: double </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: linear </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: cDNA </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: Abnormal splice acceptor site in ob </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>   (iii) HYPOTHETICAL: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (iv) ANTI-SENSE: NO </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ix) FEATURE: </entry>
</row>
<row>
<entry>          (A) NAME/KEY: Splice acceptor site  (without Glutamine) </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>AG CAG TCG GTA                                                        11 </entry>
</row>
<row>
<entry>       Ser Val </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 18: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 16 amino acids </entry>
</row>
<row>
<entry>          (B) TYPE: amino acid </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: unknown </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: peptide </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: ob peptide </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (v) FRAGMENT TYPE: internal </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (vi) ORIGINAL SOURCE: </entry>
</row>
<row>
<entry>          (A) ORGANISM: Murine </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Val Pro Ile Gln Lys Val Gln Asp Asp Thr Lys Thr Leu Ile Lys Thr </entry>
</row>
<row>
<entry>1               5                   10                  15 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 19: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 15 amino acids </entry>
</row>
<row>
<entry>          (B) TYPE: amino acid </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: unknown </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: peptide </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: ob peptide fragment </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (v) FRAGMENT TYPE: internal </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (vi) ORIGINAL SOURCE: </entry>
</row>
<row>
<entry>          (A) ORGANISM: Murine </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 19: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Leu His Pro Ile Leu Ser Leu Ser Lys Met Asp Gln Thr Leu Ala </entry>
</row>
<row>
<entry>1               5                   10                  15 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 20: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 19 amino acids </entry>
</row>
<row>
<entry>          (B) TYPE: amino acid </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: unknown </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: peptide </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: ob peptide </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (v) FRAGMENT TYPE: internal </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (vi) ORIGINAL SOURCE: </entry>
</row>
<row>
<entry>          (A) ORGANISM: Murine </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 20: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ser Lys Ser Cys Ser Leu Pro Gln Thr Ser Gly Leu Gln Lys Pro Glu </entry>
</row>
<row>
<entry>1               5                   10                  15 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     Ser Leu Asp </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>(2) INFORMATION FOR SEQ ID NO: 21: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (i) SEQUENCE CHARACTERISTICS: </entry>
</row>
<row>
<entry>          (A) LENGTH: 20 amino acids </entry>
</row>
<row>
<entry>          (B) TYPE: amino acid </entry>
</row>
<row>
<entry>          (D) TOPOLOGY: unknown </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (ii) MOLECULE TYPE: peptide </entry>
</row>
<row>
<entry>          (A) DESCRIPTION: ob peptide </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>     (v) FRAGMENT TYPE: Carboxyl terminal </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>    (vi) ORIGINAL SOURCE: </entry>
</row>
<row>
<entry>          (A) ORGANISM: Murine </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>        (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 21: </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ser Arg Leu Gln Gly Ser Leu Gln Asp Ile Leu Gln Gln Leu Asp Val </entry>
</row>
<row>
<entry>1               5                   10                  15 </entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>Ser Pro Glu Cys </entry>
</row>
<row>
<entry>            20</entry>
</row>
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"/>
</row>
</tbody>
</tgroup>
</table>
</sequence-cwu>